Successive delivery of medicines – 32 packages
Sukcesywna dostawa leków – 32 pakiety
Poland · Warszawa · how to bid here →
Your path to submission
- Deadline: 26 October at 10:00 — 22 days left.
- The submission point is stated in the notice (link on the right).
- Offer and evidence in: POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL.
- Collect your evidence — the eligibility requirements are listed above; for many of them the analysis explains how to obtain them.
Clement What the numbers say about this buyer
- In this sector the buyer awards roughly every month (479 awards, most recently September 2026) — the next award is due around October 2026 by that rhythm. The last award went to Roche Polska Sp. z o.o..n = 479
- 43% of this buyer's awards went to companies that had already won here before (735 awards since 2015, spread over 360 companies). 57% went to new names.n = 735 awards since 2015
- The median procedure drew 4 bids (360 procedures with a bid count); 31% ended with a single bidder. Sector: median 3 bids.n = 360
- 65% of the bids received came from small and medium-sized enterprises (54 procedures with a bid mix). Sector: 49%.n = 54
- 4% of awards went to companies from abroad (735 awards with a known winner country). Sector average: 5%.n = 735
From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 04/10/2026.
Foreign bidders
In Poland · Medical equipment & pharma, 5,300 contracts went to foreign companies over the last 3 years (of 277,565 recorded awards) — mostly from Germany, France, Czechia.
Submission language: POL.
Typical field: median 5 (from 269 awards).
What the buyer is looking for
Imiglucerase powder for final use for inf. (400 IU) · Eliglustat 84 mg · Avalglucosidase alfa 100 mg powder for concentrate for solution for infusion, vial 10 ml · Interferon beta - 1a solution for injection 30 µg - 6 million IU · Interferon beta - 1a solution until September and 132 µg · Interferon beta - 1b powder and solution until September 250 µg/ml · Fingolimod hard capsule 0.5 mg · Natalizumab 150 mg/1ml · Natalizumab final for solution to inf. 20 mg/ml · Peginterferon beta-1a solution up to sep. 63 µg/0.5 ml; 94 µg/0.5 ml and Peginterferon beta-1a solution until sep. 125 µg/0.5 ml · Teriflunomide 14 mg · Dimethyl fumarate 240 mg and Dimethyl fumarate 120 mg · Cladribine 10 mg · Ocrelizumabum 30 mg/ml concentrate for solution for infusion and Ocrelizumabum 40 mg/ml solution for injection · Glatiramer acetate solution for injection 40 mg/ml · Ozanimodals 230 mcg + 460 mcg and…
Show full description
… Ozanimodum 920 mcg · Ponesimodum starter pack (2x2mg + 2x3mg + 2x4mg + 1x5mg + 1x6mg + 1x7mg + 1x8mg + 1x9mg + 3x10mg) and Ponesimodum 20 mg · Ofatumumabum solution for injection 20 mg/ 0.4 ml pre-filled pen · Siponimodum 0.25 mg, Siponimodum 1 mg and Siponimodum 2 mg · Satralizumab 120 mg solution for injection in pre-filled pen · Ublituximab 150 mg/6 ml Betaine oral powder (1 g) Abobotulinumtoxin A 500 jm. and Abobotulintoin A 300 jm.
Selection criteria — in the procurement documents
The buyer states in the notice that the selection criteria are in the procurement documents (link on the right), not in the EU form. The document analysis below extracts them from there — bid and evidence in Polish.
Contract
Who has won here before
| Company | Awards | Period |
|---|---|---|
| Salus International Sp. z o.o., 40-273 NIP | 13 | 2022–2025 |
| Zarys International Group Sp. z o.o., | 11 | 2021–2025 |
| Toruńskie Zakłady Materiałów Opatrunkowych S.A | 9 | 2015–2025 |
| URTICA Sp.zo.o. | 9 | 2024–2025 |
| NEUCA S.A. | 9 | 2021–2026 |
How often this buyer tenders this
Who knows the rhythm prepares instead of reacting.
How to bid
Guide: how to apply on e-Zamówienia (Polen) → Registration, signature, fees — from the operator's bidder manual.